Management of perihilar cholangiocarcinoma in the era of multimodal therapy
about
Pharmacological treatments for primary sclerosing cholangitis: a network meta-analysisPerihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme.Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum.Liver transplantation for malignancies.Surgical resection techniques for locally advanced hilar cholangiocarcinoma.Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer.Evaluation of the effectiveness of endoscopic retrograde cholangiopancreatography in patients with perihilar cholangiocarcinoma and its effect on development of cholangitis.Risk factors and classifications of hilar cholangiocarcinoma.Conditional probability of long-term survival after resection of hilar cholangiocarcinoma.A novel combined interventional radiologic and hepatobiliary surgical approach to a complex traumatic hilar biliary stricture.miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center.Resection for Klatskin tumors: technical complexities and results
P2860
Q24193305-3D979F75-3CC7-4034-BB7A-2264F70D162FQ33742377-88B229C6-68E5-4608-AD83-256B228A7E28Q34194760-18B70817-138D-4A8B-AE3C-381B0E8D9455Q35568748-7B311F3C-0233-474E-B0AB-FE5D4E068FAEQ38194071-AB438C7C-C798-4008-88B9-F325B3068A5CQ38217327-AD414802-4372-42E7-872B-B8766CA5C1F0Q38833243-D6C91B21-AEEE-48EB-A466-04D78C44B808Q40046782-4CC672FE-FC84-4D1C-9BBA-25B4EA3F436BQ40399436-61D33A11-9153-421E-A112-3AEC70B8C2F6Q40735506-74746215-8268-4C79-BBE9-96B03157F15FQ42077153-F0507CA9-5DAA-4533-88B2-C463BD86DE9FQ42627555-8B1848EB-F798-4DA7-9ACC-884954E4A06EQ52360392-F15E1CD3-82BE-4B36-B2C8-AA0B69C1B3C5Q53099936-6CE8A598-521B-48EF-84CE-B117697A3032Q53406611-DD9E4841-9EBD-4F24-B1EC-22992840DB8BQ58554189-8D2D7D16-28CF-4E26-8B3F-086FD10E5612
P2860
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
@ast
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
@en
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
@nl
type
label
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
@ast
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
@en
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
@nl
prefLabel
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
@ast
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
@en
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
@nl
P2093
P2860
P356
P1476
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
@en
P2093
David Cosgrove
Joseph M Herman
Vicente Valero
P2860
P304
P356
10.1586/EGH.12.20
P407
P577
2012-08-01T00:00:00Z